Author:
Newsome S.D.,Guo S.,Altincatal A.,Proskorovsky I.,Kinter E.,Phillips G.,You X.,Sabatella G.
Subject
Clinical Neurology,Neurology,General Medicine
Reference34 articles.
1. Part II: Quality of life. The Canadian Burden of Illness Study Group;Burden of illness of multiple sclerosis;Can. J. Neurol. Sci.,1998
2. Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study;Calabresi;Lancet Neurol.,2014
3. The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis;Devonshire;Eur. J. Neurol.,2011
4. EuroQol – a new facility for the measurement of health-related quality of life;EuroQol;Health Policy,1990
5. European Medicines Agency, 2014. Plegridy: summary of product characteristics. Available at: 〈http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002827/WC500170302.pdf〉 (accessed 08.10.14.).
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献